Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials

[1]  D. Nelson,et al.  Survival and prognosis of patients with astrocytoma with atypical or anaplastic features , 2005, Journal of Neuro-Oncology.

[2]  Medical Research Council.  Prognostic factors for high-grade malignant glioma: Development of a prognostic index , 2004, Journal of Neuro-Oncology.

[3]  H. Eyre,et al.  Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery , 2004, Journal of Neuro-Oncology.

[4]  J. Nazzaro,et al.  The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. , 1990, Journal of neurosurgery.

[5]  C. Avezaat,et al.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[6]  Y. Shibamoto,et al.  Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  P. Gutin,et al.  Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. , 1990, International journal of radiation oncology, biology, physics.

[8]  C. Mettlin,et al.  National survey of patterns of care for brain-tumor patients. , 1989, Journal of neurosurgery.

[9]  P. Gutin,et al.  Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. , 1989, International journal of radiation oncology, biology, physics.

[10]  M. Prados,et al.  Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. , 1989, Journal of neurosurgery.

[11]  D. Trump,et al.  “Eight‐drugs‐in‐one‐day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas , 1989, Cancer.

[12]  N. Vick,et al.  Reoperation for malignant astrocytoma , 1989, Neurology.

[13]  M. Salcman.  Surgical resection of malignant brain tumors: who benefits? , 1988, Oncology.

[14]  L D Lunsford,et al.  Survival after stereotactic biopsy of malignant gliomas. , 1988, Neurosurgery.

[15]  S B Green,et al.  The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R B King,et al.  Cortical localization and monitoring during cerebral operations. , 1987, Journal of neurosurgery.

[17]  M. Mikhael,et al.  Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. , 1987, Neurosurgery.

[18]  M. Mikhael,et al.  Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. , 1987, Neurosurgery.

[19]  P. Kelly,et al.  Computer-assisted stereotaxic laser resection of intra-axial brain neoplasms. , 1986, Journal of neurosurgery.

[20]  D. Nelson,et al.  A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. , 1983, International journal of radiation oncology, biology, physics.

[21]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[22]  K. Shin,et al.  Misonidazole combined with hyperfractionation in the management of malignant glioma. , 1984, International journal of radiation oncology, biology, physics.

[23]  D. Schoenfeld,et al.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.

[24]  D. Schoenfeld,et al.  Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas , 1983, Cancer.

[25]  M. D. de Leon,et al.  CT prognostic criteria of survival after malignant glioma surgery. , 1983, AJNR. American journal of neuroradiology.

[26]  Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study. , 1983, European journal of cancer & clinical oncology.

[27]  Marshall Lf,et al.  Needle biopsy, high-dose corticosteroids, and radiotherapy in the treatment of malignant glial tumors. , 1977 .

[28]  E. Gehan,et al.  Prognostic factors for patients with brain tumors. , 1977, National Cancer Institute monograph.

[29]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[30]  L. Marshall,et al.  Needle biopsy, high-dose corticosteroids, and radiotherapy in the treatment of malignant glial tumors. , 1977, National Cancer Institute monograph.

[31]  P. Bucy,et al.  Glioblastoma multiforme: its treatment and some factors effecting survival. , 1969, Archives of neurology.

[32]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .